Riskpilot← Back to searchSign inGet full accessLaxo AB
ABActiveOrg 5591415293Nygatan 30Day spa, sauna and steam bath activities · NACE 9623Est. 20171 employees
Revenue 2025
SEK 511K
-4% vs 2024
EBITDA margin
21.9%
-1% vs 2024
Equity ratio
74.8%
Financial strength
Net profit 2025
SEK 89K
-3% vs 2024
| Revenue | SEK 511K | -4% |
| EBITDA | SEK 112K | -1% |
| Net profit | SEK 89K | -3% |
| Total assets | SEK 278K | +24% |
| Equity | SEK 208K | +23% |
| Employees | 1 | — |
Legal name
Laxo AB
Org number
5591415293
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
21 december 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Massagebehandling av privatpersoner och företagskunder, friskvård, hälsa, och försäljning av produkter inom välmående såsom kroppsvårdsprodukter, liniment, rehabtape, kosttillskott. Försäljning av klippvaror inom livsmedel, lastpallar och kassasystem. Bokföringstjänster.
Address
Nygatan 30
Email
lena@laxomassage.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 891 | 656 | 653 | 534 | 511 |
| Staff expenses | — | −166 | −254 | −255 | −282 |
| EBITDA | 137 | 63 | 32 | 113 | 112 |
| Depreciation & amort. | −41 | −41 | −1 | — | — |
| EBIT | 96 | 22 | 31 | 113 | 112 |
| Net financials | — | 0 | 3 | 3 | 1 |
| Profit before tax | 97 | 22 | 34 | 115 | 113 |
| Tax | −20 | −5 | −7 | −24 | −23 |
| Net profit | 77 | 18 | 26 | 92 | 89 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 268 | 178 | 203 | 224 | 278 |
| Equity | 172 | 90 | 102 | 169 | 208 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 96 | 89 | 101 | 56 | 70 |
| Total debt | 96 | 89 | 101 | 56 | 70 |
EBITDA margin
21.9%
This company
15.8%
Market median
+39% vs market
20212025
Equity ratio
74.8%
This company
38.2%
Market median
+96% vs market
20212025
Return on equity
43.0%
This company
18.4%
Market median
+134% vs market
20212025
Net profit margin
17.5%
This company
8.1%
Market median
+116% vs market
20212025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Laxo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Maria Charleson | Board of Directors | 0 companies |
| John Egon Charleson | Deputy Board Member | 0 companies |